Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Radiotherapy
10 evidence topics · 8 sources
Moderate-dose definitive radiotherapy when surgery is not an option
Radiotherapy combined with or compared with surgery
Dose of 56 Gy in 28 fractions and post-operative radiotherapy
“Radiotherapy to a dose of 56 Gy in 28 once-daily fractions of 2 Gy has been shown to provide adequate local control in the majority of progressive patients (III, A)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Post-operative radiation has not demonstrated a conclusive benefit after first surgery regardless of resection margins.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Radiotherapy dose, local control, and late effects
EORTC 62991-22998 multicenter prospective phase II trial: local control and response
“To determine the activity of radiotherapy in patients with inoperable desmoid-type fibromatosis (DF) a multicenter prospective phase II trial was carried out.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“(EORTC 62991-22998)” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Patients with inoperable progressive disease of primary, recurrent or incompletely resected lesions received a dose of 56 Gy in 28 fractions.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Forty-four patients (27 F/17 M) were enrolled from 2001 to 2008. Median age was 39.5 years.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Median follow-up was 4.8 years. The 3-year local control rate was 81.5% (90% one-sided confidence interval 74% to 100%). Best overall response during the first 3 years was complete response (CR) 6 (13.6%), partial response (PR) 16 (36.4%), stable disease 18 (40.9%), progressive disease 3 (6.8%) and nonassessable 1 (2.3%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Response after radiation therapy is slow with continuing regression seen even after 3 years.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
EORTC 62991-22998 multicenter prospective phase II trial: acute and late toxicity
Review of six studies of definitive radiotherapy for unresectable tumors: local control and late complications
“Among 218 identified studies, only 6 were finally included in this review. Local control was achieved in 253 of 317 patients with unresectable or unresected tumors who underwent definitive radiation therapy (the crude rate of local control was 79.8%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Frequent late complications of radiation therapy included fibrosis/contracture/joint stiffness, skin disorders, lymphedema and pain. Six patients developed secondary malignancies in the radiation field.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Adjuvant radiotherapy after resection with negative or positive margins
“Adjuvant radiotherapy after surgery with negative margins had no detectable benefit on recurrence. In contrast, after incomplete surgical resection, adjuvant radiotherapy improved recurrence rates both in patients with primary tumours (RR 1·54, 1·05 to 2·27) and in those with recurrent DF (RR 1·60, 1·12 to 2·28).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Adjuvant radiation in a surgical series
“In our series, there was no improvement in outcomes in patients who had received radiation therapy during the course of their treatment (5-year LRFS 68% vs 72% without radiation; Figure 3A).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“LRFS among patients with extremity tumors was 71% with radiation vs. 56% without (p=0.029).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote